The main problem for TH action in AHDS patients’ brains seem to derive from the restriction in TH entry into the brain parenchyma, and to a lesser extent, to the restricted entry of TH into neural cells, as other TH transporters could compensate for the absence of MCT8. This evidence concerns the gene SLC16A2 and Allan-Herndon-Dudley syndrome.